News and Community

Disease, Eu Clinical Trial Authorization, Ferrer And Prilenia Therapeutics, Hd Research, Healthcare Technology, Huntington's Disease News, Huntington's Disease Treatment, Neurodegenerative Disease Research, Phase 3 Clinical Trial, Precise-hd Study, Pridopidine

October 22, 2026

Ferrer and Prilenia Receive EU Authorization to Launch Confirmatory PRECISE-HD Study of Pridopidine for Huntington’s Disease